Dallas, TX 11/14/2008 7:30:47 AM
News / Finance

OTCPicks.com Stocks to Watch for Friday, November 14th RCCH, ANVH, VNBC, ISTA

OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/microcap.htm today to join this growing community.

Our Stocks to Watch tomorrow include RCC Holdings Corp. (OTC: RCCH), The Anviron Holding Co. (OTC: ANVH), Vineyard National Bancorp (Nasdaq: VNBC) and ISTA Pharmaceuticals Inc. (Nasdaq: ISTA).

Visit http://www.otcpicks.com to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.

RCC HOLDINGS CORPORATION (OTC: RCCH)

"Up 100.00% on Thursday"

RCC Holdings Corp. operates through its subsidiaries and provides information technology services. The company offers services such as software development, LAN and WAN integration, wireless broadband engineering, and Web design and marketing. RCC Holdings Corp. was previously known as CLIX Group, Inc. it is based in Kissimmee, Florida.

THE ANVIRON HOLDING COMPANY (OTC: ANVH)

"Up 52.94% on Thursday"

Anviron is a company dedicated to bringing to market "Clean Solutions to Complex Problems" by offering a wide range of biodegradable, environmentally friendly products and technologies that will substitute for many of the hazardous chemicals commonly used all over the world. For information about Anviron and its product offerings visit www.anviron.com.

VINEYARD NATIONAL BANCORP (NASDAQ: VNBC)

"Up 31.33% on Thursday"

Vineyard National Bancorp operates as the holding company for Vineyard Bank, National Association, which provides community banking services to businesses and individuals. It accepts non-interest bearing demand deposits, time deposits, savings deposits, certificates of deposit, negotiable order of withdrawal deposits, and money market deposits. The company also offers single family residential (SFR) luxury home construction loans; commercial construction loans, including loans for the construction of office buildings, retail space, churches, and multifamily/apartment projects; SFR tract construction loans; and commercial and residential real estate loans. In addition, it provides cash management services that comprise electronic deposit services; online banking services, including automated wire processing, electronic tax payments, electronic transfers, loan payments, bill payments, and account reconciliation; lockbox processing services; and positive pay service that allows business customers to review checks presented against accounts prior to disbursing funds. Further, the company offers courier services, ATMs, and kiosks; and exchange accommodator services. Vineyard National serves commercial businesses, commercial and residential real estate developers, retail community businesses, individuals, investors, and other local private and public organizations. As of December 31, 2007, it operated 16 full service banking centers in the communities of Chino, Corona, Covina, Crestline, Diamond Bar, Irvine, Irwindale, Lake Arrowhead, La Verne, Manhattan Beach, Rancho Cucamonga, San Diego, San Dimas, San Rafael, Upland, and Walnutin, California; and 3 regional financial centers in Orange, Los Altos, and Westlake Village, California. The company was founded in 1981 and is headquartered in Corona, California.

ISTA PHARMACEUTICALS INCORPORATED (NASDAQ: ISTA)

"Up 27.50% on Thursday"

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S.

About OTCPicks.com

OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.